MLICM
DVAX

Metropolitan Life Insurance Company (MetLife)’s Dynavax Technologies DVAX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,884
Closed -$85.4K – 626
2024
Q1 		$85.4K Sell
6,884
-591
-8% -$7.71K ﹤0.01% 1140
2023
Q4 		$105K Hold
7,475
– – ﹤0.01% 1058
2023
Q3 		$110K Buy
7,475
+391
+6% +$5.5K 0.01% 960
2023
Q2 		$91.5K Buy
7,084
+1,241
+21% +$14.1K ﹤0.01% 1062
2023
Q1 		$57.3K Sell
5,843
-1,317
-18% -$14.1K ﹤0.01% 1315
2022
Q4 		$76.2K Hold
7,160
– – ﹤0.01% 1217
2022
Q3 		$74.8K Hold
7,160
– – ﹤0.01% 1193
2022
Q2 		$90.1K Buy
7,160
+615
+9% +$6.53K ﹤0.01% 1112
2022
Q1 		$70.9K Sell
6,545
-22,036
-77% -$268K ﹤0.01% 1396
2021
Q4 		$402K Sell
28,581
-616
-2% -$10.1K 0.01% 1568
2021
Q3 		$561K Sell
29,197
-4,275
-13% -$56.8K 0.01% 1382
2021
Q2 		$330K Buy
33,472
+2,449
+8% +$22.3K ﹤0.01% 1785
2021
Q1 		$305K Buy
31,023
+1,464
+5% +$12.1K ﹤0.01% 1734
2020
Q4 		$132K Sell
29,559
-3,169
-10% -$14.3K ﹤0.01% 2209
2020
Q3 		$141K Buy
32,728
+5,218
+19% +$37.2K ﹤0.01% 2010
2020
Q2 		$244K Buy
27,510
+8,318
+43% +$42K ﹤0.01% 1674
2020
Q1 		$67.7K Sell
19,192
-9,821
-34% -$45.5K ﹤0.01% 2264
2019
Q4 		$166K Sell
29,013
-1,084
-4% -$5.8K ﹤0.01% 2042
2019
Q3 		$108K Buy
30,097
+9,796
+48% +$38K ﹤0.01% 2261
2019
Q2 		$81K Hold
20,301
– – ﹤0.01% 2413
2019
Q1 		$148K Hold
20,301
– – ﹤0.01% 2087
2018
Q4 		$186K Hold
20,301
– – ﹤0.01% 1872
2018
Q3 		$252K Hold
20,301
– – ﹤0.01% 1850
2018
Q2 		$310K Hold
20,301
– – 0.01% 1636
2018
Q1 		$403K Buy
20,301
+851
+4% +$14.7K 0.01% 1419
2017
Q4 		$364K Sell
19,450
-21,925
-53% -$440K ﹤0.01% 1491
2017
Q3 		$890K Buy
41,375
+5,959
+17% +$94.3K 0.01% 1320
2017
Q2 		$342K Buy
+35,416
New +$230K ﹤0.01% 1970
2016
Q4 		– Sell
-28,014
Closed -$294K – 2634
2016
Q3 		$294K Hold
28,014
– – ﹤0.01% 2082
2016
Q2 		$408K Buy
28,014
+1,917
+7% +$32.8K ﹤0.01% 1827
2016
Q1 		$502K Hold
26,097
– – ﹤0.01% 1573
2015
Q4 		$631K Buy
26,097
+1,660
+7% +$41.6K ﹤0.01% 1476
2015
Q3 		$600K Buy
24,437
+3,924
+19% +$111K ﹤0.01% 1518
2015
Q2 		$481K Sell
20,513
-1,027
-5% -$22.4K ﹤0.01% 1779
2015
Q1 		$483K Hold
21,540
– – ﹤0.01% 1583
2014
Q4 		$363K Sell
21,540
-1
-0% -$15 ﹤0.01% 1989
2014
Q3 		$308K Buy
21,541
+8,713
+68% +$126K ﹤0.01% 2062
2014
Q2 		$205K Sell
12,828
-8,752
-41% -$132K ﹤0.01% 2493
2014
Q1 		$388K Sell
21,580
-576
-3% -$10.7K ﹤0.01% 1984
2013
Q4 		$434K Buy
22,156
+5,988
+37% +$87.6K ﹤0.01% 1907
2013
Q3 		$194K Buy
16,168
+12,773
+376% +$161K ﹤0.01% 2448
2013
Q2 		$37K Buy
+3,395
New +$71.5K ﹤0.01% 2716

Other funds holding DVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s DVAX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Dynavax Technologies (DVAX) in Q2 2024, closing a stake of 6,884 shares — an estimated $85.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in DVAX in Q2 2013 and held it in 42 quarters. The position peaked at $890K in Q3 2017. 238 funds tracked by Wall St. Rank hold DVAX as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Dynavax Technologies position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 6,884 Dynavax Technologies shares in Q2 2024, an estimated $85.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Dynavax Technologies in Q2 2013 and held it in 42 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Dynavax Technologies position peaked at $890K in Q3 2017.
  • 238 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.